Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Ann Neurol. 2023 Apr 20;94(1):27–40. doi: 10.1002/ana.26641

Table 2:

Sleep Parameters on Intervention Nights

Placebo vs. Suvorexant 10 mg Placebo vs. Suvorexant 20 mg
NIGHT 1
Total Sleep Time (min)
Mean difference −34.88 −50.47
95% CI −97.77, 28.00 −114.6, 13.71
p-value 0.35 0.14
Sleep Efficiency (%)
Mean difference −3.94 −7.65
95% CI −11.91, 4.04 −15.79, 0.49
p-value 0.43 0.07
NREM Stage 2 (min)
Mean difference −21.73 −25.71
95% CI −79.59, 36.13 −84.77, 33.34
p-value 0.60 0.51
NREM Stage 3 (min)
Mean difference −17.35 −11.27
95% CI −54.99, 20.30 −49.69, 27.15
p-value 0.47 0.73
REM (min)
Mean difference −5.50 −20.96
95% CI −48.38, 37.38 −64.73, 22.80
p-value 0.94 0.45
NIGHT 2
Total Sleep Time (min)
Mean difference −10.54 −38.71
95% CI −88.42, 67.33 −116.6, 39.17
p-value 0.93 0.42
Sleep Efficiency (%)
Mean difference −0.10 −5.26
95% CI −10.39, 10.19 −15.55, 5.03
p-value 0.99 0.40
NREM Stage 2 (min)
Mean difference −0.43 −9.89
95% CI −61.92, 61.07 −71.38, 51.61
p-value 0.99 0.91
NREM Stage 3 (min)
Mean difference −10.90 −3.49
95% CI −52.16, 30.36 −44.75, 37.77
p-value 0.77 0.97
REM (min)
Mean difference −2.30 −21.46
95% CI −36.68, 32.09 −55.85, 12.93
p-value 0.98 0.27

Mg: milligrams; min: minutes; CI: confidence intervals; NREM: non-rapid eye movement; REM: rapid eye movement.

*

p-values corrected using Dunnett’s multiple comparison’s test